JPH0452636A - Silver halide emulsion having high sensitivity and good developability - Google Patents
Silver halide emulsion having high sensitivity and good developabilityInfo
- Publication number
- JPH0452636A JPH0452636A JP16313690A JP16313690A JPH0452636A JP H0452636 A JPH0452636 A JP H0452636A JP 16313690 A JP16313690 A JP 16313690A JP 16313690 A JP16313690 A JP 16313690A JP H0452636 A JPH0452636 A JP H0452636A
- Authority
- JP
- Japan
- Prior art keywords
- silver halide
- emulsion
- grains
- silver
- crystal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 Silver halide Chemical class 0.000 title claims abstract description 103
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 97
- 239000004332 silver Substances 0.000 title claims abstract description 97
- 239000000839 emulsion Substances 0.000 title claims abstract description 89
- 230000035945 sensitivity Effects 0.000 title abstract description 20
- 239000013078 crystal Substances 0.000 claims abstract description 66
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 239000002245 particle Substances 0.000 abstract description 77
- 230000012010 growth Effects 0.000 abstract description 34
- 239000000463 material Substances 0.000 abstract description 12
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 abstract 3
- 238000000034 method Methods 0.000 description 44
- 229910021612 Silver iodide Inorganic materials 0.000 description 19
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 18
- 229940045105 silver iodide Drugs 0.000 description 18
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 239000007864 aqueous solution Substances 0.000 description 12
- 229910052740 iodine Inorganic materials 0.000 description 12
- 239000011630 iodine Substances 0.000 description 12
- 238000011161 development Methods 0.000 description 10
- 238000009826 distribution Methods 0.000 description 10
- 239000000975 dye Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000012452 mother liquor Substances 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 230000001235 sensitizing effect Effects 0.000 description 6
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 6
- 239000000523 sample Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010070834 Sensitisation Diseases 0.000 description 4
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000008313 sensitization Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000010894 electron beam technology Methods 0.000 description 3
- 238000004453 electron probe microanalysis Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000002250 progressing effect Effects 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- GGZHVNZHFYCSEV-UHFFFAOYSA-N 1-Phenyl-5-mercaptotetrazole Chemical compound SC1=NN=NN1C1=CC=CC=C1 GGZHVNZHFYCSEV-UHFFFAOYSA-N 0.000 description 1
- JAAIPIWKKXCNOC-UHFFFAOYSA-N 1h-tetrazol-1-ium-5-thiolate Chemical compound SC1=NN=NN1 JAAIPIWKKXCNOC-UHFFFAOYSA-N 0.000 description 1
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 1
- LRUDIIUSNGCQKF-UHFFFAOYSA-N 5-methyl-1H-benzotriazole Chemical compound C1=C(C)C=CC2=NNN=C21 LRUDIIUSNGCQKF-UHFFFAOYSA-N 0.000 description 1
- WSGURAYTCUVDQL-UHFFFAOYSA-N 5-nitro-1h-indazole Chemical compound [O-][N+](=O)C1=CC=C2NN=CC2=C1 WSGURAYTCUVDQL-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001663154 Electron Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- XEIPQVVAVOUIOP-UHFFFAOYSA-N [Au]=S Chemical compound [Au]=S XEIPQVVAVOUIOP-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002156 adsorbate Substances 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- XYXNTHIYBIDHGM-UHFFFAOYSA-N ammonium thiosulfate Chemical compound [NH4+].[NH4+].[O-]S([O-])(=O)=S XYXNTHIYBIDHGM-UHFFFAOYSA-N 0.000 description 1
- 229940101006 anhydrous sodium sulfite Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 1
- 229910001864 baryta Inorganic materials 0.000 description 1
- CJPQIRJHIZUAQP-MRXNPFEDSA-N benalaxyl-M Chemical compound CC=1C=CC=C(C)C=1N([C@H](C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-MRXNPFEDSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000001661 cadmium Chemical class 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- YGZZDQOCTFVBFC-UHFFFAOYSA-L disodium;1,5-dihydroxypentane-1,5-disulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C(O)CCCC(O)S([O-])(=O)=O YGZZDQOCTFVBFC-UHFFFAOYSA-L 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000009647 facial growth Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 150000002496 iodine Chemical class 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002503 iridium Chemical class 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000006224 matting agent Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical compound N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 150000003283 rhodium Chemical class 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 1
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 150000003475 thallium Chemical class 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野〕
本発明はハロゲン化銀乳剤に関し、特に高感度で現像性
が良好なハロゲン化銀乳剤に関するものである。DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a silver halide emulsion, and particularly to a silver halide emulsion with high sensitivity and good developability.
近年、写真用のハロゲン化銀乳剤に対する要請はますま
す厳しく、高感度、優れた粒状性、高鮮鋭性、低いカブ
リ濃度及び十分高い光学濃度等の写真性能に対して、ま
すます高水準の要求がなされている。また、現像性が良
好であることが要請されている。In recent years, demands on silver halide emulsions for photography have become increasingly strict, with increasingly high standards required for photographic performance such as high sensitivity, excellent graininess, high sharpness, low fog density, and sufficiently high optical density. is being done. In addition, it is required that the developability is good.
これらの内、高感度乳剤を提供する試みとして、各種の
技術が提案されている。例えば、沃臭化銀乳剤で沃化銀
含有率が10モル%以下である乳剤が良く知られている
。また、これらの乳剤を調製する方法としては、従来か
らアンモニア法、中性法、酸性法等のpH条件、PAg
条件を制御する方法、混合法としてはシングルジェット
法、ダブルジェット法等が知られている。Among these, various techniques have been proposed in an attempt to provide high-sensitivity emulsions. For example, silver iodobromide emulsions having a silver iodide content of 10 mol % or less are well known. In addition, conventional methods for preparing these emulsions include pH conditions such as the ammonia method, neutral method, and acidic method, PAg
As a method of controlling conditions and a mixing method, a single jet method, a double jet method, etc. are known.
これらの公知技術を基盤にして、高感度化、粒状性の改
良、高鮮鋭性及び低カプリを達成する目的のために精緻
に技術手段が検討され、実用化されてきた。特に臭化銀
及び沃臭化銀乳剤においては、晶相、粒度分布はもとよ
り、個々のハロゲン化銀粒子内での沃化銀の濃度分布ま
で制御された乳剤が研究されてきた。Based on these known techniques, technical means have been elaborately studied and put into practical use for the purpose of achieving high sensitivity, improved graininess, high sharpness, and low capri. In particular, research has been carried out on silver bromide and silver iodobromide emulsions in which not only the crystal phase and grain size distribution but also the concentration distribution of silver iodide within each silver halide grain is controlled.
上に述べてきたような高域度、優れた粒状性、高鮮鋭性
、低いカブリ濃度及び十分高いカバリングパワー等の写
真性能を達成するための手段、特に高感度化のための最
も正統な方法は、ハロゲン化銀の量子効率を向上させる
ことである。この目的のために固体物理の知見等が積極
的に取り入れられている。この量子効率を理論的に計算
した研究によれば、粒度分布を狭くして、単分散性乳剤
をつくることが量子効率を向上させるのに有効となる。Means for achieving photographic performance such as high frequency range, excellent graininess, high sharpness, low fog density, and sufficiently high covering power as described above, especially the most orthodox method for increasing sensitivity. The purpose is to improve the quantum efficiency of silver halide. For this purpose, knowledge of solid state physics is actively incorporated. According to research that theoretically calculated quantum efficiency, narrowing the particle size distribution to create a monodisperse emulsion is effective in improving quantum efficiency.
更に加えて、ハロゲン化銀乳剤を増感する化学増感と呼
ばれる工程において、低カブリを保ったまま効率よく高
感度を達成するためにも単分散性乳剤が有利であろうと
推論される。In addition, it is inferred that monodisperse emulsions are advantageous in order to efficiently achieve high sensitivity while maintaining low fog in a process called chemical sensitization in which silver halide emulsions are sensitized.
工業的な単分散性乳剤調製には、特開昭54−4852
1号に記載されているように厳密なPAg及びpHの制
御のもとに、理論上京められた銀イオン及びハロゲン化
物イオンの反応系への供給速度の制御及び十分な撹拌条
件が必要とされる。これらの条件下で製造されるハロゲ
ン化銀乳剤は立方体、8面体、14面体のいずれかの形
状の(100)面と(111)面を様々の割合で有して
いる、いわゆる正常晶粒子からなる。そして、このよう
な正常晶粒子により高感度化し得ることが知られている
。For industrial monodisperse emulsion preparation, JP-A-54-4852
As described in No. 1, under strict control of PAg and pH, control of the theoretically determined supply rate of silver ions and halide ions to the reaction system, and sufficient stirring conditions are required. Ru. Silver halide emulsions produced under these conditions are made from so-called normal crystal grains having cubic, octahedral, or tetradecahedral (100) and (111) planes in various proportions. Become. It is known that such normal crystal particles can increase sensitivity.
また高感度を得られるハロゲン化銀粒子として、特開昭
61−35440号、同60−222842号にはそれ
ぞれ(110)面を有する写真特性の優れた沃臭化銀粒
子が開示されており、また特公昭55−42737号に
は、カブリの少ないものとして(110)面を持つ菱1
2面体の塩臭化銀粒子を含む写真乳剤が開示されている
。Furthermore, as silver halide grains capable of obtaining high sensitivity, silver iodobromide grains having excellent photographic properties and having (110) planes are disclosed in Japanese Patent Application Laid-open Nos. 61-35440 and 60-222842, respectively. In addition, in Japanese Patent Publication No. 55-42737, there is a rhombus with (110) face as a product with less fog.
Photographic emulsions containing dihedral silver chlorobromide grains are disclosed.
一方、特開昭61−83531号には、 (110)面
の中央に稜線を有する結晶面を持つ臭化銀、沃臭化銀粒
子が開示されており、これにより更に高感度化し得るこ
とが示されている。この結晶面は、非常に高次な結晶面
であると考えられ、その特性については、特開昭61−
83531号に述べられている。On the other hand, JP-A No. 61-83531 discloses silver bromide and silver iodobromide grains having a crystal plane with a ridge line in the center of the (110) plane, which can further improve sensitivity. It is shown. This crystal plane is considered to be a very high-order crystal plane, and its characteristics have been described in
No. 83531.
該結晶面は(nnl)と表され、(331)面等の例が
示される。The crystal plane is expressed as (nnl), and examples such as the (331) plane are shown.
その他の面については特開昭62−124551号、同
62−124550号、同62−123447号に記載
がある。Other aspects are described in JP-A Nos. 62-124551, 62-124550, and 62-123447.
一方、従来から高感度写真フィルムに適するハロゲン化
銀乳剤として多分散性の双晶粒子からなる沃臭化銀乳剤
が知られている。On the other hand, silver iodobromide emulsions comprising polydisperse twin crystal grains have been known as silver halide emulsions suitable for high-speed photographic films.
また、特開昭58−113927号その他には偏平双晶
粒子を含む沃臭化銀乳剤が開示されている。Moreover, silver iodobromide emulsions containing oblate twin grains are disclosed in Japanese Patent Application Laid-open No. 58-113927 and others.
一方、化学増感処理の分野では、正常晶に対する化学増
感反応は晶相依存性が大きく、例えば通常の方法では、
(100)面に比べ(111)面には硫黄増感核が沢山
できてしまうため、潜像形成が分散的になり効率が悪く
、従って、増悪効率が悪いことが知られている。よって
、上記のような(111)面を有する形態のハロゲン化
銀粒子の実用化は不利、または困難とされてきた。On the other hand, in the field of chemical sensitization, the chemical sensitization reaction for normal crystals is highly dependent on the crystal phase.
It is known that since more sulfur sensitizing nuclei are formed on the (111) plane than on the (100) plane, latent image formation becomes dispersive and inefficient, resulting in poor exacerbation efficiency. Therefore, it has been considered disadvantageous or difficult to put silver halide grains having the above-mentioned (111) plane into practical use.
例えば特開昭50−63914号及びドイツ特許出願(
OLS)2,419,798号には、臭化銀含有モJL
/比率カ80%以上の立方体型粒子の単分散性ハロゲン
化銀粒子乳剤を硫黄増感した後、ヒドロキシテトラザイ
ンデン化合物を含有させると感度が増大することが記載
されており、かっこの公報には立方体以外の結晶形、例
えば、実質的に(111)面で囲まれた八面体粒子では
感度はかえって減少するが増加してもその程度はわずか
であることが併記されている。For example, Japanese Patent Application Laid-open No. 50-63914 and German patent application (
OLS) No. 2,419,798, silver bromide containing molybdenum
It is stated that the sensitivity increases when a hydroxytetrazaindene compound is added after sulfur sensitization of a monodisperse silver halide grain emulsion of cubic grains with a ratio of 80% or more, and the parenthetical publication states that It is also noted that for crystal shapes other than cubic, for example, octahedral grains substantially surrounded by (111) planes, the sensitivity actually decreases, but even if it increases, the extent of the increase is small.
前記したようにハロゲン化銀感光材料の写真特性改善に
向かって結晶形態面からの研究は瞠目すべき発展を進め
つつあるが、双晶の微細な凹部もしくは蝕像の凹部を除
けばそのほとんどは外に凸な結晶に止っており、結晶面
上に明確な大きな凹凸部を有する結晶に関する研究は少
ない。As mentioned above, research from the viewpoint of crystal morphology is progressing at an impressive rate toward improving the photographic properties of silver halide photosensitive materials, but most of the research, with the exception of minute concave portions of twins or concave portions of eroded images, is progressing. There is little research on crystals that are outwardly convex and have clearly large unevenness on the crystal plane.
公知技術として開示されているものとしては、特開昭5
8−106532号公報の記載では8面体または14面
体結晶の(111)面の中央部にくぼみを有するハロゲ
ン化銀乳剤がある。また特開昭61−75337号公報
には、表面から内部に向かって空洞の導通部を有するハ
ロゲン化銀粒子を含むハロゲン化銀乳剤が開示されてい
る。また正常晶以外の平板状粒子としては、特開昭63
−311244号公報において、(111)面からなる
対向せる平行な主平面からなる平板状粒子のその主表面
の中心部に(ぼみもしくは空間を有するハロゲン化銀粒
子からなるハロゲン化銀乳剤が開示されている。As for what is disclosed as a publicly known technique, Japanese Unexamined Patent Publication No. 5
No. 8-106532 describes a silver halide emulsion having a depression in the center of the (111) plane of an octahedral or tetradecahedral crystal. Further, JP-A-61-75337 discloses a silver halide emulsion containing silver halide grains having hollow conductive portions from the surface toward the inside. In addition, as tabular grains other than normal crystals, JP-A-63
Japanese Patent No. 311244 discloses a silver halide emulsion consisting of silver halide grains having a depression or space in the center of the main surface of a tabular grain consisting of opposing parallel main planes consisting of (111) planes. has been done.
それらはいずれもハロゲン化銀粒子上のくぼみもしくは
空間に潜像もしくは現像開始点を集中して、これによる
高感度化、保存性の向上、現像性向上を目的としている
。All of them aim to concentrate latent images or development starting points in the depressions or spaces on the silver halide grains, thereby increasing sensitivity, improving storage stability, and improving developability.
しかしそれらはいずれも−度形成されたハロゲン化銀粒
子の一部をハロゲン化銀溶剤を用いて溶解、取り除く工
程を含み、ハロゲン化銀粒子表面上のくぼみ、もしくは
空間以外の微細なハロゲン化銀粒子表面上の凹凸をも増
やしてしまい、潜像の集中化、現像開始点の集中化とい
う点で充分な効果が得られていなかった。However, all of them involve a step of dissolving and removing a part of the formed silver halide grains using a silver halide solvent. The unevenness on the particle surface also increased, and sufficient effects were not obtained in terms of concentration of latent images and concentration of development starting points.
また、特開昭63−244030号、特開昭63−26
4739号、特開昭62−89949号、特開昭62−
269948号、特開昭63−38930号、特開平1
−179140号の各公報には、ハロゲン化銀粒子が該
表面にハロゲン化銀突起物を有するものであるハロゲン
化銀乳剤が開示されている。しかしそれらはいずれも、
突起物がその面の面積の小部分しか占めていないもので
あり、また、沃化銀を含まない塩臭化銀であったり、ハ
ロゲン化銀突起物が実質的に塩化銀であったり、ハロゲ
ン化銀突起物が非常に多数存在していたりしており、高
感度化という点で充分な効果が得られるものではなかっ
た。Also, JP-A-63-244030, JP-A-63-26
No. 4739, JP-A-62-89949, JP-A-62-
No. 269948, JP-A-63-38930, JP-A-1
Patent No. 179140 discloses a silver halide emulsion in which silver halide grains have silver halide protrusions on their surfaces. But all of them are
The protrusions occupy only a small portion of the area of the surface, and the protrusions may be made of silver chlorobromide that does not contain silver iodide, or the protrusions may be made of silver chloride or silver halide. A very large number of silver oxide protrusions were present, and a sufficient effect of increasing sensitivity could not be obtained.
上記のように、従来技術にあっては、潜像、現像開始点
の集中化による高感度化、現像性向上は不充分であり、
上記以外の方法で結晶形態面からの研究が待ちのぞまれ
ていた。As mentioned above, with the conventional technology, it is insufficient to achieve high sensitivity and improve development performance by concentrating the latent image and development starting point.
Research from the perspective of crystal morphology using methods other than those described above has been awaited.
本発明は上記背景においてなされたもので、上記したよ
うに結晶形態面からの研究により、高感度化及び現像性
向上を実現したハロゲン化銀乳剤を提供しようとするこ
とを目的とする。The present invention was made against the above background, and an object of the present invention is to provide a silver halide emulsion that achieves high sensitivity and improved developability through research from the aspect of crystal morphology as described above.
本発明者らは鋭意研究を行った結果、上記本発明の目的
は、8面体または14面体結晶の(111)面のいずれ
か少なくとも1つの面の中心部が盛り上がり、該盛り上
がり部が線面の面積の50%以上を占めるものであるハ
ロゲン化銀粒子を含むハロゲン化銀乳剤によって達成さ
れることを見い出し、本発明を完成した。As a result of intensive research, the present inventors have found that the above-mentioned object of the present invention is such that the center of at least one of the (111) planes of an octahedral or tetradecahedral crystal is raised, and the raised part is a linear plane. They have discovered that this can be achieved by using a silver halide emulsion containing silver halide grains that occupy 50% or more of the area, and have completed the present invention.
本発明においてr (111)面の中心部が盛り上が」
るとは、(111)面の中心付近(厳密に中心でなくて
もほぼ中心として作用し得る位置であればよい)におい
て、即ち縁辺部ではない位置において、面が盛り上がっ
て、各種形状の広い(面積の50%以上を占める)突状
部分(突起)が存在することをいう。該盛り上がり部は
、四角形であることが多いが、調整条件で変化する。盛
り上がり部の径(その盛り上がり部の投影面積を円に換
算したときの円の直径で表す)は、母体の8面体または
14面体粒子の径によって変化するが、好ましくは0.
005 u m 〜20 a m、より好ましくは0.
005μm〜2.0μmである。突起の高さは、立方体
粒子の(111)面に垂直なく111>方向に0.00
5 u m以上であることが好ましく、より好ましくは
0.02μm以上である。In the present invention, the center of the r (111) plane is raised.
This means that the surface bulges near the center of the (111) surface (it doesn't have to be exactly the center, but should be at a position that can almost act as the center), that is, it is not the edge, and the surface has a wide variety of shapes. This refers to the presence of a protrusion (occupying 50% or more of the area). The raised portion is often rectangular, but it changes depending on the adjustment conditions. The diameter of the raised portion (represented by the diameter of a circle when the projected area of the raised portion is converted into a circle) varies depending on the diameter of the parent octahedral or tetradecahedral particle, but is preferably 0.
005 um to 20 am, more preferably 0.005 um to 20 am.
005 μm to 2.0 μm. The height of the protrusion is not perpendicular to the (111) plane of the cubic particle, but 0.00 in the 111> direction.
It is preferably 5 μm or more, more preferably 0.02 μm or more.
例えば、後記詳述する本発明の乳剤の一例である乳剤E
M−1の粒子構造を示す第1図の写真の粒子構造例につ
いて言えば、8面体の(111)面の各面が3角形(厳
密には各頂点が削がれた形の3角形)をなし、該3角形
とほぼ同心でこれよりひとまわり小さいほぼ同形の3角
形状の盛り上がり部が、各面に形成された構造になって
いる。For example, emulsion E, which is an example of the emulsion of the present invention which will be described in detail later,
Regarding the grain structure example shown in the photograph in Figure 1 showing the grain structure of M-1, each face of the (111) face of the octahedron is a triangle (strictly speaking, a triangle with each vertex cut off). It has a structure in which a triangular raised portion, which is approximately concentric with the triangle and slightly smaller than the triangle, is formed on each surface.
以下本発明について、更に詳細に説明する。The present invention will be explained in more detail below.
一般にハロゲン化銀乳剤に含有されているハロゲン化銀
結晶粒子の結晶面には、該面に配列される銀イオン、ハ
ロゲン化物イオンの稠密度、格子エネルギー、表面エネ
ルギー、或いは成長条件に対応して、特定のミラー指数
を有する結晶面が優勢に発現して結晶に特定の晶相を与
える。更に各結晶粒子を囲繞する成長条件に粒子サイズ
尺度での差異があるときには、同ミラー指数の面である
にも拘らず、面の大きさを異にして夫々の粒子に晶癖を
生ずる。In general, the crystal planes of silver halide crystal grains contained in silver halide emulsions have different density, lattice energy, surface energy, or growth conditions of silver ions and halide ions arranged on the plane. , crystal planes with specific Miller indices are dominantly expressed, giving the crystal a specific crystal phase. Furthermore, when there is a difference in the growth conditions surrounding each crystal grain on a grain size scale, the grains will have different crystal habits even though they have the same Miller index.
一方、結晶に晶相を与える゛′終局的結晶面となる平面
は、該面の法線方向の成長速度が最小の面である” (
A、 Johnsen、 1910)ので、成長条件を
選ぶことによって、立方晶系に属するハロゲン化銀結晶
にも所定の晶相を有する結晶形を与えることができる。On the other hand, the plane that becomes the ultimate crystal plane that gives the crystal a crystalline phase is the plane that has the minimum growth rate in the direction normal to that plane.'' (
A. Johnsen, 1910) Therefore, by selecting the growth conditions, even silver halide crystals belonging to the cubic system can be given a crystal form having a predetermined crystal phase.
例えば立方晶系のハロゲン化銀に晶相として六面体(立
方体)結晶形を与えるには、立方体面上における成長速
度即ち銀イオン及びハロゲン化物イオンの沈着が、他の
ミラー指数の結晶面より遅い成長条件が与えられればよ
い。For example, in order to give cubic silver halide a hexahedral (cubic) crystalline phase, the growth rate on cubic planes, that is, the deposition of silver ions and halide ions, is slower than on crystal planes with other Miller indices. As long as the conditions are given.
更にホスト粒子として(111)面に囲まれた八面体の
ハロゲン化銀結晶粒子から六面体(立方体)に晶相を変
える場合には、立方体面(100)の成長を抑える成長
条件を与えてハロゲン化銀を追加沈澱させてゆくと、中
間的に立方八面体即ち八面体の6個の頂点が削がれた形
の14面体が出現し、(111)面は漸次縮退し、遂に
立方体面だけの結晶粒子となり、それ以後はハロゲン化
銀の追加に伴った立方体結晶粒子が肥大してゆく。Furthermore, when changing the crystal phase from octahedral silver halide crystal grains surrounded by (111) planes to hexahedral (cubic) host grains, growth conditions are provided to suppress the growth of cubic (100) planes. As silver is further precipitated, a cuboctahedron, that is, a tetradecahedron in which the six vertices of the octahedron have been shaved off, appears in the middle, and the (111) plane gradually degenerates until it becomes a cubic octahedron with only six vertices removed. The crystal grains become crystal grains, and thereafter the cubic crystal grains enlarge as silver halide is added.
逆に立方体結晶粒子をホスト粒子として8面体結晶粒子
へ導くこともできる。Conversely, cubic crystal grains can also be used as host particles to lead to octahedral crystal grains.
同様にして、例えば三八面体結晶粒子も立方体結晶粒子
をホスト粒子として導くことができる。Similarly, cubic crystal grains can also be introduced as host grains, for example trioctahedral crystal grains.
即ち三八面体結晶面の法線方向の成長が他のミラー指数
の面より遅くなる成長条件を選んでハロゲン化銀の沈澱
を続けると、まず三八面体結晶面が認められるようにな
り、続いて遂にはホスト粒子は三八面体結晶面で占めら
れるに到る。In other words, if silver halide precipitation is continued by selecting growth conditions in which growth in the normal direction of trioctahedral crystal planes is slower than planes of other Miller indices, trioctahedral crystal planes will first be recognized, and then Eventually, the host grains are occupied by trioctahedral crystal faces.
その他四六面体、偏菱形24面体、カバ面体の結晶面を
もつ結晶粒子についても、各々の晶相を与える面の成長
を抑える成長条件を選ぶことによって所望の結晶粒子を
得ることができる。Desired crystal grains can also be obtained with other crystal grains having tetrahexahedral, rhomboid icosahedral, and hippophedral crystal faces by selecting growth conditions that suppress the growth of the faces that give each crystal phase.
前記各種の晶相をもつハロゲン化銀粒子の成長条件は、
ハロゲン化銀組成、結晶面に配列されるイオンの稠密度
、温度、格子もしくは表面エネルギー、吸着物質、ハロ
ゲン化銀溶剤等多岐に亘る因子によって左右され、また
結晶面上でのハロゲン化銀の沈着を遅らせる成長調節剤
(growth modifier)が因子として加え
られる。The growth conditions for the silver halide grains having various crystal phases are as follows:
Deposition of silver halide on crystal surfaces is influenced by a wide variety of factors such as silver halide composition, density of ions arranged on crystal planes, temperature, lattice or surface energy, adsorbate, silver halide solvent, etc. A growth modifier is added as a factor to retard the process.
成長調節剤としては既に多数の化合物が公知であり、写
真用ハロゲン化銀に対しては、その表面に吸着性を有す
るシアニン色素等の写真用色素類、アザインデン、イミ
ダゾール等の安定剤、カブリ抑制剤の中に有用なものが
知られている(前記開示特許公報、特願昭62−159
280号等)。Many compounds are already known as growth regulators, and for photographic silver halide, there are photographic dyes such as cyanine dyes that have adsorption properties on the surface, stabilizers such as azaindene and imidazole, and fog suppressants. Some useful agents are known (see the above-mentioned Disclosure Patent Publication, Japanese Patent Application No. 62-159).
No. 280, etc.).
しかしながら現時点では前記したような結晶成長に影響
する多岐に亘る因子と生成する結晶形を関係づける理論
に乏しく、特に本発明の如く結晶粒子に盛り上がり部を
有する面を生成させる未踏技術分野の理論的裏付は無に
等しく、殆ど試行錯誤の下にその意図する結晶形を具現
する方法を探索せざるをえない。However, at present, there is a lack of theory that relates the various factors that influence crystal growth as described above and the crystal form produced, and in particular, there is a lack of theory in the unexplored technical field of producing surfaces with raised portions on crystal grains as in the present invention. There is no proof, and we have no choice but to search for ways to realize the intended crystal form through trial and error.
本発明の乳剤は8面体または14面体結晶の(111)
面のいずれか少なくとも1つの面(好ましくは(111
)面のすべての面)の中心部に盛り上がり部を有するハ
ロゲン化銀粒子を含むが、かかる粒子結晶の作成は、必
ずしも容易ではない。本発明者は、このような粒子結晶
を得るべく、結晶粒子の調製条件、例えば1)Ag、温
度或いはハロゲン化銀添加速度及び条件揺動について試
行錯誤を行い、次のようにして本発明の乳剤が得られる
ことを見い出した。即ち、例えば、次に示すような製造
方法を挙げることができる。The emulsion of the present invention has (111) octahedral or tetradecahedral crystals.
at least one of the faces (preferably (111
Although it includes silver halide grains having a raised portion at the center of all surfaces (), it is not necessarily easy to create such grain crystals. In order to obtain such grain crystals, the present inventor conducted trial and error regarding the preparation conditions of crystal grains, such as 1) Ag, temperature or silver halide addition rate, and fluctuation of conditions, and achieved the method of the present invention as follows. It has been found that an emulsion can be obtained. That is, for example, the following manufacturing method can be mentioned.
最表面の法度含有率が10モル%以下で、8面体もしく
は14面体結晶の形状をもつハロゲン化銀粒子の生成及
び/または成長を行う。更に該粒子の最表面の法度含有
率よりも好ましくは10モル%以上、より好ましくは1
5モル%以上の法度含有率の高い相を成長させる。形状
が整った時点での、前記当初の粒子により構成される部
分を低沃度層、その上に形成される法度含有率の高い相
を高沃度層と称すれば、その時、該高沃度相に対する、
該低沃度層の体積比としては、20%以上であることが
好ましい。また該ハロゲン化銀粒子成長時のpAgとし
ては、9以下が好ましい。Silver halide grains having an octahedral or tetradecahedral crystal shape are produced and/or grown, with the outermost surface having a normal content of 10 mol % or less. Furthermore, it is preferably 10 mol% or more, more preferably 1 mol % or more than the legal content on the outermost surface of the particles
A phase with a high legal content of 5 mol% or more is grown. When the shape is adjusted, the part composed of the original particles is called a low iodine layer, and the phase with a high normal content formed thereon is called a high iodine layer. For the degree phase,
The volume ratio of the low iodine layer is preferably 20% or more. The pAg during growth of the silver halide grains is preferably 9 or less.
本発明のハロゲン化銀乳剤に含まれる上記8面体または
14面体結晶の(111)面のいずれかの少なくとも1
つの面の中心部に盛り上がり部を有するハロゲン化銀粒
子(以下適宜「本発明のハロゲン化銀粒子jなどという
こともある)は、酸性法、中性法及びアンモニア法のい
ずれで得られたものでもよい。該粒子は連続的に成長さ
せてもよいし、段階的に種粒子を作りつつ成長させても
よい。種粒子をつくる方法と成長させる方法は同じであ
っても、異なってもよい。At least one of the (111) planes of the octahedral or tetradecahedral crystals contained in the silver halide emulsion of the present invention
Silver halide grains having a raised portion at the center of one surface (hereinafter also referred to as "silver halide grains j of the present invention") are those obtained by any of the acid method, neutral method, and ammonia method. The particles may be grown continuously or may be grown stepwise while creating seed particles.The method of creating seed particles and the method of growing them may be the same or different. .
本発明のハロゲン化銀乳剤のハロゲン化銀組成に限定は
ないが、実質的に臭化銀、沃臭化銀であることが好まし
い。本発明の乳剤は、沃素を含有することが好ましいが
、この場合粒子成長において、沃素イオンは沃化カリウ
ム溶液のようなイオン溶液として添加されてもよく、ま
た、成長中のハロゲン化銀粒子よりも溶解度積の小さい
粒子として添加されてもよい。この沃素の供給は、溶解
度積の小さいハロゲン化銀粒子(以下に詳述)として添
加する方がより好ましい。Although there is no limitation on the silver halide composition of the silver halide emulsion of the present invention, it is preferably substantially silver bromide or silver iodobromide. The emulsion of the present invention preferably contains iodine, but in this case, during grain growth, iodine ions may be added as an ionic solution such as a potassium iodide solution, and the iodine ions may be added as an ionic solution such as a potassium iodide solution, may also be added as particles with a small solubility product. It is more preferable to supply this iodine in the form of silver halide grains (described in detail below) having a small solubility product.
即ち本発明のハロゲン化銀粒子は、該粒子の成長過程の
少な(とも−期間において、該本発明のハロゲン化銀粒
子(粒子成長過程についての以下の説明においては、便
宜上、rAgX粒子(1)」と称する)よりも溶解度積
が同等以下のハロゲン化銀微粒子(同じ(rAgX粒子
(2)」と称する)の存在下において、そのハロゲン化
銀粒子の粒子成長が行われることが好ましい一態様であ
る。That is, the silver halide grains of the present invention are produced during the growth process of the grains (rAgX grains (1) for convenience in the following explanation of the grain growth process). In one embodiment, it is preferable that the grain growth of the silver halide grains is carried out in the presence of silver halide fine grains (referred to as "rAg be.
溶解度積が同等以下とは、AgX粒子(2)の溶解度積
が、AgX粒子(1)の溶解度積と同じであるか、それ
より小さいことをいう。また本明細書中溶解度積とは、
通常の化学的意味におけるものである。The solubility product being equal or lower means that the solubility product of the AgX particles (2) is the same as or smaller than the solubility product of the AgX particles (1). In addition, the solubility product in this specification is
In the ordinary chemical sense.
このような態様を採用する場合、AgX粒子(1)の溶
解度積と同等、もしくはそれより小さい溶解度積のAg
X粒子(2)が、AgX粒子(1)の成長過程の少なく
とも一時期において存在し、該AgX粒子(2)の存在
下にAgX粒子(1)の成長が行われる。ここで、Ag
X粒子(2)は、AgX粒子(1)の粒子成長要素()
飄ロゲンイオン液や、銀イオン液等)の供給終了までに
存在させて、AgX粒子(1)を成長させるように用い
ることができる。When adopting such an embodiment, Ag having a solubility product equal to or smaller than that of AgX particles (1)
The X particles (2) are present during at least one period of the growth process of the AgX particles (1), and the growth of the AgX particles (1) is performed in the presence of the AgX particles (2). Here, Ag
X particles (2) are particle growth elements () of AgX particles (1)
It can be used to grow the AgX particles (1) by making it exist until the supply of the chloride ion solution, silver ion solution, etc.) is finished.
このAgX粒子(2)の平均粒径は、−iに、AgX粒
子(1)の平均粒径より小さいが、場合によっては大き
いこともある。かつ、このAgX粒子(2)は、一般に
実質的に感光性は有さない程度のものである。このAg
X粒子(2)の平均粒径は、0.001〜0.7μmで
あることが好ましく、0.01〜0.3 u mが更に
好ましく、特に0.1〜0.01μmが好ましい。The average particle size of the AgX particles (2) is smaller than the average particle size of the AgX particles (1), but may be larger depending on the case. Moreover, the AgX particles (2) generally have substantially no photosensitivity. This Ag
The average particle diameter of the X particles (2) is preferably 0.001 to 0.7 μm, more preferably 0.01 to 0.3 μm, and particularly preferably 0.1 to 0.01 μm.
AgX粒子(2)は、遅くともAgX粒子(1)の成長
が終了するまでに、AgX粒子(1)の調製の場となる
懸濁系(以下、母液と称す)中に存在せしめることが好
ましい。It is preferable that the AgX particles (2) are allowed to exist in a suspension system (hereinafter referred to as mother liquor) that serves as a place for preparing the AgX particles (1) at the latest by the time the growth of the AgX particles (1) is completed.
ハロゲン化銀種粒子を用いる場合には、AgX粒子(2
)は該種粒子より前に母液中に存在せしめてもよいし、
種粒子を含む母液中に粒子成長組成物に先立って添加し
てもよいし、粒子成長要素を添加している途中に添加し
てもよいし、上述の添加時期の内、2以上の時期に分け
て添加してもよい。When using silver halide seed grains, AgX grains (2
) may be present in the mother liquor before the seed particles,
It may be added to the mother liquor containing seed particles prior to the particle growth composition, it may be added during the addition of particle growth elements, or it may be added at two or more of the above-mentioned addition times. It may be added separately.
種粒子を用いず、ハロゲン化銀核形成後粒子成長を行う
場合には、核形成後にAgX粒子(2)を添加すること
が好ましく、粒子成長要素の添加前であっても、添加の
途中でもよく、2以上の時期に分けてもよい。When grain growth is performed after silver halide nucleation without using seed grains, it is preferable to add AgX grains (2) after nucleation, either before or during the addition of grain growth elements. Often, it can be divided into two or more periods.
また、AgX粒子(2)及び粒子成長要素の添加法とし
ては、−括して添加してもよいし、連続的に、または断
続的に添加してもよい。Furthermore, the AgX particles (2) and the particle growth element may be added all at once, continuously, or intermittently.
AgX粒子(2)及び粒子成長要素は、粒子成長に適合
した速度でpH,pAg、温度等をコントロールした条
件下で、ダブルジェット方式〇如き多ジェット方式によ
り母液に添加することが好ましい。The AgX particles (2) and the particle growth element are preferably added to the mother liquor by a multi-jet method such as a double jet method under conditions where pH, pAg, temperature, etc. are controlled at a rate suitable for particle growth.
AgX粒子(2)及びハロゲン化銀種粒子は、母液中で
調製してもよいし、母液外で調製した後、母液に添加し
てもよい。The AgX grains (2) and silver halide seed particles may be prepared in the mother liquor, or may be prepared outside the mother liquor and then added to the mother liquor.
AgX粒子(2)の調製に用いる水溶性銀塩溶液として
は、アンモニア性銀塩溶液が好ましい。As the water-soluble silver salt solution used for preparing the AgX particles (2), an ammoniacal silver salt solution is preferable.
AgX粒子(2)のハロゲン組成としては、例えばAg
X粒子(1)が沃臭化銀である場合には、沃化銀または
成長中の沃臭化銀粒子よりも沃素含有率の高い沃臭化銀
が好ましく、例えばAgX粒子(1)が塩臭化銀である
場合には、臭化銀または成長中の塩臭化銀よりも臭素含
有率の高い塩臭化銀が好ましい。AgX粒子(1)が沃
臭化銀の場合、AgX粒子(2)は沃化銀であることが
特に好ましい。The halogen composition of the AgX particles (2) is, for example, Ag
When the X grains (1) are silver iodobromide, silver iodobromide having a higher iodine content than silver iodide or growing silver iodobromide grains is preferable; for example, if the AgX grains (1) are When silver bromide is used, silver chlorobromide having a higher bromine content than silver bromide or growing silver chlorobromide is preferred. When the AgX grains (1) are silver iodobromide, it is particularly preferable that the AgX grains (2) are silver iodide.
AgX粒子(1)が沃臭化銀または塩沃臭化銀である場
合には、粒子成長に用いられる沃素が全てAgX粒子(
2)として供給されることが好ましいが、本発明の効果
を損なわない範囲で一部をハロゲン化物水溶液として供
給してもよい。When the AgX grains (1) are silver iodobromide or silver chloroiobromide, all the iodine used for grain growth is absorbed by the AgX grains (1).
Although it is preferable to supply it as 2), a part of it may be supplied as a halide aqueous solution to the extent that the effects of the present invention are not impaired.
また、ハロゲン化銀粒子の成長時に、アンモニア、チオ
エーテル、チオ尿素等の公知のハロゲン化銀溶剤を存在
させることができる。Further, during the growth of silver halide grains, a known silver halide solvent such as ammonia, thioether, thiourea, etc. can be present.
ハロゲン化銀粒子は、粒子を形成する過程及び/または
成長させる過程で、カドミウム塩、亜鉛塩、鉛塩、タリ
ウム塩、イリジウム塩、ロジウム塩及び鉄塩及びそれら
の錯塩から選ばれる少なくとも1種を用いて金属イオン
を添加し、粒子内部及び/または粒子表面にこれらの金
属元素を含有させることができ、また適当な還元的雰囲
気におくことにより、粒子内部及び/または粒子表面に
還元増悪核を付与できる。Silver halide grains contain at least one selected from cadmium salts, zinc salts, lead salts, thallium salts, iridium salts, rhodium salts, iron salts, and complex salts thereof during the process of forming and/or growing the grains. By adding metal ions to the particles and/or on the surface of the particles, it is possible to contain these metal elements inside the particles and/or on the surface of the particles, and by placing them in an appropriate reducing atmosphere, reduction aggravation nuclei can be added inside the particles and/or on the particle surfaces. Can be granted.
本発明のハロゲン化銀乳剤は、ハロゲン化銀粒子の成長
の終了後に不要な可溶性塩類を除去してもよいし、ある
いは含有させたままでもよい。該塩類を除去する場合に
は、リサーチ・ディスクロジ+ (Research
Disclosure 以下RDと略す)17643
号■項に記載の方法に基づいて行うことができる。In the silver halide emulsion of the present invention, unnecessary soluble salts may be removed after the growth of silver halide grains is completed, or they may remain contained. When removing the salts, please refer to the Research Discology +
Disclosure (hereinafter abbreviated as RD) 17643
It can be carried out based on the method described in item (■).
また、本発明のハロゲン化銀粒子の平均粒径は、0.0
5〜30μmが好ましく、0.1〜3.0μmがより好
ましい。Further, the average grain size of the silver halide grains of the present invention is 0.0
5-30 micrometers are preferable, and 0.1-3.0 micrometers are more preferable.
本発明のハロゲン化銀乳剤は、粒子サイズ分布の広い多
分散乳剤、粒子サイズ分布の狭い単分散乳剤など、任意
の構成をとることができる。The silver halide emulsion of the present invention can have any configuration, such as a polydisperse emulsion with a wide grain size distribution or a monodisperse emulsion with a narrow grain size distribution.
本発明のハロゲン化銀乳剤は、単独の乳剤から成るもの
であっても、数種類の乳剤を混合して成るものであって
もよい。The silver halide emulsion of the present invention may be composed of a single emulsion or a mixture of several types of emulsions.
本発明を実施する際には、単分散乳剤とすることが好ま
しい。本発明のハロゲン化銀乳剤は、単分散性の良好な
乳剤として安定に得ることができる。When carrying out the present invention, it is preferable to use a monodispersed emulsion. The silver halide emulsion of the present invention can be stably obtained as an emulsion with good monodispersity.
単分散のハロゲン化銀乳剤としては、平均粒径fを中心
に±20%の粒径範囲内に含まれるハロゲン化銀重量が
、全ハロゲン化銀粒子重量の60%以上であるものが好
ましく、より好ましくは70%以上、更に好ましくは8
0%以上である。The monodisperse silver halide emulsion is preferably one in which the weight of silver halide contained within a grain size range of ±20% around the average grain size f is 60% or more of the weight of all silver halide grains. More preferably 70% or more, still more preferably 8
It is 0% or more.
ここに、平均粒径Y、粒径riを有する粒子の頻度ni
とri”との積n1Xri3が最大となるときの粒径r
iを定義する(有効数字3桁、最小桁数字は4捨5人す
る)。Here, the average particle size Y, the frequency ni of particles having particle size ri
The particle size r when the product n1Xri3 of
Define i (3 significant digits, minimum digit is 4 to 5 digits).
即ち粒径riとは、球状のハロゲン化銀粒子の場合は、
その直径、また球状以外の形状の粒子の場合は、その投
影像を同面積の円像に換算した時の直径である。That is, the grain size ri is, in the case of spherical silver halide grains,
In the case of particles having a shape other than spherical, the diameter is the diameter when the projected image is converted into a circular image with the same area.
粒径は、例えば該粒子を電子顕微鏡で1万倍から5万倍
に拡大して撮影し、そのプリント上の粒子直径または投
影時の面積を実測することによって得ることができる(
測定粒子個数は無差別にi、ooo個以上有ることとす
る)。The particle size can be obtained, for example, by photographing the particle with an electron microscope at a magnification of 10,000 to 50,000 times and measuring the particle diameter or projected area on the print (
The number of particles to be measured is assumed to be at least i,ooo indiscriminately).
特に好ましい高度の単分散乳剤は
によって分布の広さを定義したとき20%以下のもので
あり、更に好ましくは15%以下のものである。Particularly preferred highly monodispersed emulsions are those with a distribution width of 20% or less, more preferably 15% or less, when the width of the distribution is defined as follows.
ここに平均粒径及び標準偏差は上記定義riから求める
ものとする。Here, the average particle diameter and standard deviation shall be determined from the above definition ri.
単分散乳剤を得る方法としては、種粒子を含むゼラチン
溶液中に、水溶性銀塩溶液と水溶性ハライド溶液をp、
Ag及びpHの制御下ダブルジェット法によって加える
ことによって得る方法があり、このような手段を用いる
ことができる。A method for obtaining a monodisperse emulsion is to add a water-soluble silver salt solution and a water-soluble halide solution to a gelatin solution containing seed particles.
There is a method of adding by double jet method under control of Ag and pH, and such means can be used.
添加速度の決定に当たっては、特開昭54−48521
号、同5B −49938号を参考にできる。In determining the addition rate, refer to JP-A-54-48521.
No. 5B-49938.
更に高度な単分散乳剤を得る方法として特開昭60−1
22935号に開示されたテトラザインデン存在下の成
長方法が適用できる。As a method for obtaining a more advanced monodispersed emulsion, JP-A-60-1
The growth method in the presence of tetrazaindene disclosed in No. 22935 can be applied.
また本発明のハロゲン化銀乳剤は、各粒子がその形状に
おいて同一性を保っていることが好ましい。Further, in the silver halide emulsion of the present invention, each grain preferably maintains identity in its shape.
各粒子がその形状において同一性を保つとは、少なくと
も10,000倍以上の走査電子顕微鏡写真で粒子の形
状を観察した場合に、少なくとも晶癖、及び粒径が着目
する個々の粒子で同一であることを言う。特に表面の微
細構造を観察するためには、2kV以下の低加速電圧を
使用することが好ましい。Each particle maintains the same shape in its shape, which means that when the shape of the particle is observed using a scanning electron micrograph at a magnification of at least 10,000 times, at least the crystal habit and particle size are the same for each individual particle of interest. say something. In particular, in order to observe the fine structure of the surface, it is preferable to use a low acceleration voltage of 2 kV or less.
例えば正常晶粒子を例に挙げて説明すると、個々の粒子
が、
■(111) 、 (100) 、 (331)等の血
止率が同一であること、
■ハロゲン化銀粒子がコア/シェル粒子である場合、シ
ェル形成時にシェルが形成されていない部分を粒子中に
持たないこと、
■表面の凹凸等の平面性が同一であること、■双晶粒子
を含まないこと、
0粒径が明らかに異なる微小、粗大な粒子や、2以上の
粒子が付着して成る凝集粒子(これらは顕微鏡観察によ
り知ることができる)を含まないこと、
等について個々の粒子がすべて同一である場合が、ここ
でいう形状の同一性を保った一例である。For example, if we take normal crystal grains as an example, the individual grains: (1) have the same hemostasis rate such as (111), (100), (331), etc., and (2) silver halide grains are core/shell grains. , the particle must have no part where no shell is formed during shell formation, ■ The flatness of the surface, such as surface irregularities, must be the same. ■ It must not contain twin grains, and the grain size is clearly 0. In this case, the individual particles are all the same in that they do not contain different fine or coarse particles or aggregated particles made up of two or more particles attached (these can be seen by microscopic observation). This is an example of maintaining the same shape.
具体的には好ましくは、乳剤中の粒子数の70%以上が
、上記形状において同一性を保った粒子であることが好
ましく、より好ましくは80%以上、更に好ましくは9
0%以上が上記形状において同一性を保った粒子である
ことが好ましい。Specifically, it is preferable that 70% or more of the number of grains in the emulsion are grains that maintain the same identity in the above shape, more preferably 80% or more, still more preferably 9.
It is preferable that 0% or more of the particles maintain the same identity in the above shape.
また本発明のハロゲン化銀乳剤は、その個々のハロゲン
化銀粒子の沃化銀含有率において同一性を保っているこ
とが好ましい。Further, it is preferable that the silver halide emulsion of the present invention maintains the same silver iodide content of each silver halide grain.
本発明の乳剤における個々のハロゲン化銀粒子の沃化銀
含有率、及び平均沃化銀含有率は、EPMA法(Ele
ctron Probe Micro Analyze
r法)を用いることにより求めることができる。The silver iodide content of individual silver halide grains and the average silver iodide content in the emulsion of the present invention are determined by the EPMA method (Ele
ctron Probe Micro Analyze
r method).
この方法は、乳剤粒子を互いに接触しないように良く分
散したサンプルを作製し、電子ビームを照射する電子線
励起によるX線分析により極微小な部分の元素分析を行
う技術である。This method is a technique in which a well-dispersed sample is prepared so that the emulsion grains do not come into contact with each other, and elemental analysis of extremely small portions is performed by X-ray analysis using electron beam excitation by irradiating the sample with an electron beam.
この方法により、各粒子から放射される銀及び沃素の特
性X線強度を求めることにより、個々の粒子のハロゲン
組成が決定できる。By this method, the halogen composition of each grain can be determined by determining the characteristic X-ray intensities of silver and iodine emitted from each grain.
少なくとも50個の粒子についてEPMA法により沃化
銀含有率を求めれば、それらの平均から平均沃化銀含有
率を求めることができる。If the silver iodide content of at least 50 grains is determined by the EPMA method, the average silver iodide content can be determined from the average thereof.
測定に用いる装置は特に特殊な仕様は必要ではないが、
後記する本発明の実施例では、日本電子■製X線マイク
ロアナライザーJ X A −8621を用いて、乳剤
の沃化銀含有率を測定した。測定は、電子線ダメージを
除くために、低温に冷却して行った。The equipment used for measurement does not require any special specifications, but
In the examples of the present invention described later, the silver iodide content of the emulsion was measured using an X-ray microanalyzer JXA-8621 manufactured by JEOL Ltd. The measurements were performed while cooling to a low temperature to eliminate electron beam damage.
また、個々の粒子の沃化銀含有率の相対標準偏差は、上
記測定における少なくとも50個の乳剤粒子の沃化銀含
有率を測定した際の沃化銀含有率の標準偏差を平均沃化
銀含有率で除した値に100を乗じて得られる値である
。The relative standard deviation of the silver iodide content of individual grains is the standard deviation of the silver iodide content when measuring the silver iodide content of at least 50 emulsion grains in the above measurement. This value is obtained by multiplying the value divided by the content rate by 100.
本発明の乳剤は、その個々の沃臭化銀粒子の沃化銀含有
率の相対標準偏差が20%以下のものが好ましい。本発
明の乳剤は、粒子間の沃素含有率が更により均一になっ
ていることが好ましい。即ちEPMA法により粒子間の
沃素含有率の分布を測定した時に、相対標準偏差が20
%以下であることが好ましいが、更に15%以下、特に
10%以下であることが好ましい。The emulsion of the present invention is preferably one in which the relative standard deviation of the silver iodide content of each individual silver iodobromide grain is 20% or less. In the emulsion of the present invention, it is preferable that the iodine content among the grains is even more uniform. That is, when the distribution of iodine content among particles was measured by the EPMA method, the relative standard deviation was 20.
% or less, more preferably 15% or less, particularly 10% or less.
本発明のハロゲン化銀乳剤は、常法により化学増感する
ことができる。The silver halide emulsion of the present invention can be chemically sensitized by conventional methods.
本発明のハロゲン化銀乳剤は、写真業界において増感色
素として知られている色素を用いて、所望の波長域に光
学的に増感できる。増感色素は単独で用いてもよいが、
2種以上を組み合わせて用いてもよい。The silver halide emulsion of the present invention can be optically sensitized to a desired wavelength range using dyes known as sensitizing dyes in the photographic industry. Sensitizing dyes may be used alone, but
You may use two or more types in combination.
ハロゲン化銀乳剤には、カブリ防止剤、安定剤等を加え
ることができる。該乳剤のバインダーとしては、ゼラチ
ンを用いるのが有利である。Antifoggants, stabilizers, etc. can be added to the silver halide emulsion. Gelatin is advantageously used as binder for the emulsion.
本発明のハロゲン化銀乳剤を用いて感光材料を形成する
場合、感光材料の乳剤層、その他の親水性コロイド層は
、硬膜することができ、また、可塑剤、水不溶性または
難溶性合成ポリマーの分散物(ラテックス)を含有させ
ることができる。When a light-sensitive material is formed using the silver halide emulsion of the present invention, the emulsion layer and other hydrophilic colloid layers of the light-sensitive material can be hardened, and plasticizers, water-insoluble or poorly soluble synthetic polymers, etc. can contain a dispersion (latex) of
本発明のハロゲン化銀乳剤は、カラー写真用感光材料を
形成するために有効に用いることができ、その乳剤層に
用いる場合には、一般に発色カプラーを含有させて用い
られる。The silver halide emulsion of the present invention can be effectively used to form a light-sensitive material for color photography, and when used in the emulsion layer, it is generally used in the form of a color-forming coupler.
更に色補正の効果を有しているカラードカプラ、競合カ
プラー及び現像主薬の酸化体とのカップリングによって
各種のフラグメント、即ち現像促進剤、漂白促進剤、現
像剤、ハロゲン化銀溶剤、調色剤、硬膜剤、カブリ剤、
カブリ防止剤、化学増感剤、分光増感剤、及び滅惑剤の
ような写真的に有用なフラグメントを放出する化合物を
用いることができる。Furthermore, various fragments such as development accelerators, bleaching accelerators, developing agents, silver halide solvents, and toning agents can be produced by coupling with colored couplers, competing couplers, and oxidized products of developing agents, which have the effect of color correction. , hardener, fogging agent,
Compounds that release photographically useful fragments such as antifoggants, chemical sensitizers, spectral sensitizers, and desensitizers can be used.
本発明のハロゲン化銀乳剤を用いて感光材料を形成する
場合、該感光材料には、フィルター層、ハレーション防
止層、イラジェーション防止層等の補助層を設けること
ができる。これらの層中及び/または乳剤層中には、現
像処理中に感光材料から流出するかもしくは漂白される
染料が含有させられてもよい。When a photosensitive material is formed using the silver halide emulsion of the present invention, the photosensitive material can be provided with auxiliary layers such as a filter layer, an antihalation layer, and an antiirradiation layer. These layers and/or the emulsion layers may contain dyes that are leached or bleached from the light-sensitive material during the development process.
感光材料には、ホルマリンスカベンジャ、蛍光増白剤、
マット剤、滑剤、画像安定剤、界面活性剤、色カプリ防
止剤、現像促進剤、現像遅延剤や漂白促進剤を添加でき
る。Photosensitive materials include formalin scavengers, optical brighteners,
A matting agent, a lubricant, an image stabilizer, a surfactant, a color anti-capri agent, a development accelerator, a development retardant and a bleach accelerator can be added.
感光材料の支持体としては、ポリエチレン等をラミネー
トした紙、ポリエチレンテレフタレートフィルム、バラ
イタ紙、三酢酸セルロース等、任意のものを用いること
ができる。As the support for the photosensitive material, any material can be used, such as paper laminated with polyethylene or the like, polyethylene terephthalate film, baryta paper, cellulose triacetate, and the like.
本発明の感光材料を用いて色素画像を得るには、露光後
、通常知られているカラー写真処理を行うことによるこ
とができる。A dye image can be obtained using the light-sensitive material of the present invention by performing a commonly known color photographic process after exposure.
次に実施例によって、本発明を説明する。但し当然のこ
とであるが、本発明は以下の実施例によって限定される
ものではない。Next, the present invention will be explained by examples. However, it goes without saying that the present invention is not limited to the following examples.
実施例−1
(沃化銀微粒子乳剤Al−1の調製)
反応容器に、オセインゼラチン5重量%を含む水溶液を
加え、40°Cで撹拌しながら、3.5N硝酸銀水溶液
及び3.5N沃化力リウム水溶液各々1モルを、30分
を所要して定速で添加した。Example-1 (Preparation of silver iodide fine grain emulsion Al-1) An aqueous solution containing 5% by weight of ossein gelatin was added to a reaction vessel, and while stirring at 40°C, 3.5N silver nitrate aqueous solution and 3.5N iodine gelatin were added. 1 mol of each aqueous solution was added at a constant rate over a period of 30 minutes.
添加中のPAgは、常法のPAg制御手段で、13.5
に保った。The PAg being added was controlled at 13.5 using conventional PAg control means.
I kept it.
生成した沃化銀は、平均粒径0.06μmの、βAgI
とT−Aglの混合物であった。The produced silver iodide is βAgI with an average grain size of 0.06 μm.
and T-Agl.
以下この乳剤を乳剤Al−1とする。This emulsion will hereinafter be referred to as emulsion Al-1.
(乳剤EM−1の作成)
以下に示す4種類の溶液を用いて乳剤EM−1(本発明
の乳剤に該当)を作成した。(Preparation of Emulsion EM-1) Emulsion EM-1 (corresponding to the emulsion of the present invention) was prepared using the following four types of solutions.
水溶液(a−1)
化合物(1)
(平均分子量−1300)
水溶液(a−2)
水溶液(a−3)
沃化銀微粒子を含有する乳剤溶液(a−4)温度60°
Cの状態で激しく撹拌された上記組成の水溶液(a−1
)に、0.407モル相当の種乳剤(平均粒径0.27
μm、平均AgI含有率2モル%)を加え、pH及びP
Agを酢酸とKBr水溶液を用いて調整した。Aqueous solution (a-1) Compound (1) (average molecular weight -1300) Aqueous solution (a-2) Aqueous solution (a-3) Emulsion solution containing silver iodide fine grains (a-4) Temperature 60°
Aqueous solution of the above composition (a-1
), seed emulsion equivalent to 0.407 mol (average particle size 0.27
μm, average AgI content 2 mol%), pH and P
Ag was prepared using acetic acid and KBr aqueous solution.
しかる後にpH及びPAgを表−1に示すようにコント
ロールしながら、水溶液(a−2)(a3)及び(a−
4)を、各々表−29表−3及び表−4に示すような流
量で、トリプルジェット法により添加した。Thereafter, while controlling the pH and PAg as shown in Table 1, the aqueous solutions (a-2), (a3) and (a-
4) were added by the triple jet method at the flow rates shown in Tables 29 and 3 and 4, respectively.
添加終了後、常法により脱塩水洗を行い、ゼラチンを含
む水溶液に分散した。After the addition was completed, the mixture was washed with desalinated water in a conventional manner and dispersed in an aqueous solution containing gelatin.
電子顕微鏡観察によって、この乳剤は平均粒径0.46
μmで、全ハロゲン化銀粒子の92%が(111)面に
突起を有する8面体粒子よりなり、粒径分布の変動係数
が11.2%の高度な単分散乳剤であることがわかった
。According to electron microscopy, this emulsion has an average grain size of 0.46.
It was found that the emulsion was a highly monodisperse emulsion in which 92% of all silver halide grains were composed of octahedral grains having protrusions on the (111) plane, and the coefficient of variation in grain size distribution was 11.2%.
表−5に、この乳剤中のハロゲン化銀粒子の処力士の粒
子構造を示す。Table 5 shows the grain structure of the silver halide grains in this emulsion.
第1図は本発明に係るこの乳剤中のハロゲン化銀粒子の
電子顕微鏡観察写真である。FIG. 1 is an electron microscope photograph of silver halide grains in this emulsion according to the present invention.
表−1
表−2
(a−2)の添加パターン
表−3
(a−3)の添加パターン
表−4
(a−4)の添加パターン
→はpHやPAgを一定に保つこと、\は連続的に低下
させること、↓は急激に低下させることを示す。Table-1 Table-2 Addition pattern of (a-2) Table-3 Addition pattern of (a-3) Table-4 Addition pattern of (a-4) → means to keep pH and PAg constant, \ means continuous ↓ indicates a sudden decrease.
表−5
実施例−2
特開昭61−246740号、特開昭61−27574
1号、特開昭61−286845号公報に示された方法
によって、実施例−1で調製した乳剤EM−1と同一の
ノ10ゲン組成、粒径分布、平均粒径で、かつ最終形状
が各(111)面に盛り上がりを有さない8面体粒子で
ある比較乳剤EM−2を調製した。Table-5 Example-2 JP-A-61-246740, JP-A-61-27574
No. 1, by the method shown in JP-A No. 61-286845, the emulsion EM-1 had the same composition, grain size distribution, and average grain size as those of the emulsion EM-1 prepared in Example-1, and the final shape was Comparative emulsion EM-2, which is an octahedral grain having no protrusions on each (111) plane, was prepared.
作成したEM−1,2の各乳剤に、最適に金イオウ増感
を施し、AgX1モル当たり下記の増感色素(I)を3
50■、及び増感色素(II)を240■添加し、緑感
性に分光増感した。次いでTAI及び1−フェニル−5
−メルカプトテトラゾールを加えて安定化した。(Ag
Xはハロゲン化銀を示す)。Each of the prepared EM-1 and EM-2 emulsions was optimally sensitized with gold sulfur, and 3 sensitizing dyes (I) below were added per mol of AgX.
50 µm and 240 µm of sensitizing dye (II) were added to spectral sensitize to green sensitivity. Then TAI and 1-phenyl-5
- Stabilized by adding mercaptotetrazole. (Ag
X represents silver halide).
更に、AgX1モル当たり5X10−’モルの下記マゼ
ンタカプラー(M −1) 、6.2 xlO−’モル
の下記マゼンタカプラー(M−2)、及び4. OXl
0−3モルの下記カラードマゼンタカプラー(CM−1
)を、ジ−t−ノニルフタレートに溶解し、ゼラチンを
含む水溶液中に乳化分散して得た分散液をそれぞれの乳
剤に添加し、ついで延展剤、硬膜剤などの一般的な写真
添加剤を加えて塗布液を作成し、下引きされたフィルム
ベース上に常法により塗布、乾燥して、試料Nα101
.102を作成した。Furthermore, 5×10 −′ moles of the following magenta coupler (M −1) per mole of AgX, 6.2×1 O −′ moles of the following magenta coupler (M-2), and 4. OXl
0-3 mol of the following colored magenta coupler (CM-1
) is dissolved in di-t-nonyl phthalate and emulsified and dispersed in an aqueous solution containing gelatin, and a dispersion obtained is added to each emulsion, and then common photographic additives such as a spreading agent and a hardening agent are added. was added to prepare a coating solution, coated on the undercoated film base by a conventional method, dried, and prepared as sample Nα101.
.. 102 was created.
Ct
増感色素■
M
常法に従い試料Nfl101.102の各々に、イエロ
ーフィルターを介し、ウェッジ露光を行った。次いで、
下記現像処理液で下記処理工程(I)(II)により処
理を行い、感度を求めた。Ct Sensitizing dye ■M Wedge exposure was performed on each of the samples Nfl101 and 102 through a yellow filter according to a conventional method. Then,
The following processing steps (I) and (II) were performed using the following developing solution to determine the sensitivity.
処理工程(1)(35°C)
現 像 15秒定 着
25秒水 洗
25秒乾 燥 1
5秒処理工程(II) (35°C)
現 像 25秒定 着
25秒水 洗
25秒乾 燥 1
5秒各処理工程において使用した処理液組成は下記に示
す。Processing process (1) (35°C) Development 15 seconds fixation
Wash with water for 25 seconds
Dry for 25 seconds 1
5 seconds processing step (II) (35°C) Development 25 seconds fixation
Wash with water for 25 seconds
Dry for 25 seconds 1
The composition of the treatment liquid used in each 5 second treatment step is shown below.
く現像液〉
亜硫酸カリウム 55.0 gハ
イドロキノン 25.0g1−
フェニル−3−ピラゾリドン 1.2gホウ酸
10.0 g水酸化ナトリウ
ム 21.0 gトリエチレングリ
コール 17.5g5−メチルベンゾトリ
アゾール 0.07g5−ニトロインダゾール
0.14g1−フェニル−5−メルカプト
テトラゾール O,OISgグ
ルタルアルデヒド重亜硫酸塩 15.0 g氷酢
酸 16.0 g臭化カ
リウム 4.0gトリエチレン
テトラミン六酢酸 2.5g水を加えて11に仕
上げ、p H=10.20に調整する。Developer solution> Potassium sulfite 55.0 g Hydroquinone 25.0 g 1-
Phenyl-3-pyrazolidone 1.2g boric acid
10.0 g Sodium hydroxide 21.0 g Triethylene glycol 17.5 g 5-Methylbenzotriazole 0.07 g 5-Nitroindazole
0.14 g 1-phenyl-5-mercaptotetrazole O, OIS g Glutaraldehyde bisulfite 15.0 g Glacial acetic acid 16.0 g Potassium bromide 4.0 g Triethylenetetraminehexaacetic acid 2.5 g Add water to make 11. Adjust pH to 10.20.
く定着液〉
エチレンジアミン四酢酸・2
ナトリウム塩 5.0g酒石酸
3.0gチオ硫酸アン
モニウム 130.9g無水亜硫酸ナト
リウム 7.3gホウ酸
7.0g酢酸(90wt%)
5.5g酢酸ナトリウム3水塩
25.8g硫酸アルミニウム18水塩
14.6 g硫酸(50圓t%)
6.77 g水を加えてlrに仕上げ、p
H=4.20に調整する。Fixer> Ethylenediaminetetraacetic acid, di-sodium salt 5.0g Tartaric acid 3.0g Ammonium thiosulfate 130.9g Anhydrous sodium sulfite 7.3g Boric acid
7.0g acetic acid (90wt%)
5.5g Sodium acetate trihydrate
25.8g aluminum sulfate 18 hydrate
14.6 g sulfuric acid (50 gt%)
Add 6.77 g water and finish to lr, p
Adjust to H=4.20.
結果を表−6に示す。感度は、最小濃度(かぶり) +
0.1を与える露光量の逆数で表し、試料N。The results are shown in Table-6. Sensitivity is the minimum density (fog) +
Sample N is expressed as the reciprocal of the exposure amount giving 0.1.
102の処理工程(I)の感度を100とした時の相対
値で表す。It is expressed as a relative value when the sensitivity of the processing step (I) of 102 is set to 100.
第1図は、実施例〜1で得られた本発明の乳剤である乳
剤EM−1のハロゲン化銀粒子の粒子構造を示す電子顕
微鏡写真である。FIG. 1 is an electron micrograph showing the grain structure of silver halide grains of emulsion EM-1, which is an emulsion of the present invention obtained in Examples 1 to 1.
Claims (1)
か少なくとも1つの面の中心部が盛り上がり、該盛り上
がり部が該面の面積の50%以上を占めるものであるハ
ロゲン化銀粒子を含むハロゲン化銀乳剤。Halogen containing silver halide grains in which the center of at least one {111} face of a 1-, octahedral, or 14-hedral crystal is raised, and the raised part occupies 50% or more of the area of the face. Silver emulsion.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16313690A JPH0452636A (en) | 1990-06-21 | 1990-06-21 | Silver halide emulsion having high sensitivity and good developability |
| EP91110004A EP0462581A1 (en) | 1990-06-21 | 1991-06-19 | Silver halide photographic emulsion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16313690A JPH0452636A (en) | 1990-06-21 | 1990-06-21 | Silver halide emulsion having high sensitivity and good developability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0452636A true JPH0452636A (en) | 1992-02-20 |
Family
ID=15767887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16313690A Pending JPH0452636A (en) | 1990-06-21 | 1990-06-21 | Silver halide emulsion having high sensitivity and good developability |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0452636A (en) |
-
1990
- 1990-06-21 JP JP16313690A patent/JPH0452636A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3025585B2 (en) | Silver halide emulsion | |
| US5358842A (en) | Silver halide photographic light-sensitive material | |
| JP2794247B2 (en) | Silver halide emulsion | |
| JPH0452636A (en) | Silver halide emulsion having high sensitivity and good developability | |
| JPH07146522A (en) | Silver halide emulsion | |
| JP2719540B2 (en) | High sensitivity silver halide photographic material | |
| JPH07234470A (en) | Silver halide emulsion | |
| JPH03120528A (en) | Silver halide emulsion high in sensitivity and improved in fog and graininess and manufacture of the same | |
| JPH0456840A (en) | Silver halide emulsion having high sensitivity and good developability | |
| JP2907964B2 (en) | Silver halide emulsion with high sensitivity and good developability | |
| JPH04123042A (en) | Silver halide emulsion having high sensitivity and good developability | |
| JPH0456845A (en) | Silver halide emulsion having high sensitivity and good developability | |
| JPH0456841A (en) | Silver halide emulsion having high sensitivity and good developability | |
| JPH055094B2 (en) | ||
| JPH0452637A (en) | Silver halide emulsion having high sensitivity and good developability | |
| JPH04123043A (en) | Silver halide emulsion having high sensitivity and good developability | |
| JP3041377B2 (en) | Silver halide emulsion and light-sensitive material containing the emulsion | |
| JPH07113738B2 (en) | Improved silver halide photographic light-sensitive material with less fog over time | |
| JP2840897B2 (en) | Silver halide emulsion and method for producing the same | |
| EP0462581A1 (en) | Silver halide photographic emulsion | |
| JP2683625B2 (en) | Silver halide photographic material | |
| JP2926448B2 (en) | Method for producing silver halide emulsion and silver halide photographic material | |
| JPH02120849A (en) | Silver halide crystal grains and silver halide photosensitive material | |
| JP3388914B2 (en) | Silver halide emulsion | |
| JPH0451037A (en) | Silver halide emulsion high in sensitivity and pressure resistance |